Skip to content

Incyte INCY Intangibles (Net)

Intangibles (Net) at other companies

Celldex Therapeutics logo
Celldex TherapeuticsCLDX
$27.19M0.0%
Arcutis Biotherapeutics, Inc. logo
Arcutis Biotherapeutics, Inc.ARQT
$14.25M-13.6%
ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX

Other financials

Income statement

See full
Revenue$1.7B+37.7%
Gross profit$1.6B+38.0%
Operating income$697.9M+31.6%
Net income$585.6M+44.6%
EPS (diluted)$2.81+37.7%

Balance sheet

See full
Cash & equivalents$4.0B+104%
Total debt$38.3M-9.8%
Total equity$6.3B+52.1%
Total assets$7.9B+35.2%

Cash flow

See full
Operating cash flow$507.7M+1,035%
CapEx$1.6M-43.5%
Free cash flow$509.3M+1,069%

Valuation

See full
Market cap$23.51B+73.1%
Enterprise value$19.56B+67.7%
P/E14.6×-1.0×
P/S+1.1×

Profitability

See full
Gross margin92.6%-0.3pp
Operating margin30.6%+4.8pp
Net margin27.7%+8.7pp
FCF margin34%+12.3pp

Returns & leverage

See full
Return on equity30.7%+6.4pp
Debt / equity0.0×
Current ratio4.6×+1.7×

Where this comes from

Reported directly by Incyte in its filing.

Tagged under the XBRL concept us-gaap:OtherIntangibleAssetsNet.

The official record: Incyte’s 10-Q, filed July 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Incyte's intangibles (net).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Incyte's intangibles (net)?
Incyte (INCY) reported intangibles (net) of $103.2M in Q2 2026.
How has Incyte's intangibles (net) changed year-over-year?
Incyte's intangibles (net) decreased by 18.4% year-over-year, from $126.42M to $103.2M.
What is the long-term trend for Incyte's intangibles (net)?
Over 5 years (2020 to 2025), Incyte's intangibles (net) has grown at a -7.4% compound annual growth rate (CAGR), from $172.29M to $117.13M.
What does intangibles (net) mean?
Identifiable intangible assets (patents, trademarks, customer relationships, technology) net of accumulated amortization — excluding goodwill.